Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

John Mitchell

Concepts (437)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonectomy
40
2024
152
6.140
 Why?
Anesthesiology
11
2023
87
3.220
 Why?
Thoracic Surgery
16
2025
132
3.130
 Why?
Mycobacterium Infections, Nontuberculous
11
2024
363
3.110
 Why?
Esophageal Neoplasms
19
2025
321
2.780
 Why?
Lung Neoplasms
39
2024
2526
2.380
 Why?
Internship and Residency
16
2023
1147
2.230
 Why?
Clinical Competence
18
2023
1118
2.200
 Why?
Thoracic Surgical Procedures
13
2025
73
2.170
 Why?
Lung Diseases
9
2024
767
1.620
 Why?
Echocardiography, Transesophageal
7
2022
96
1.550
 Why?
Thoracic Surgery, Video-Assisted
11
2022
43
1.550
 Why?
Nontuberculous Mycobacteria
6
2024
205
1.540
 Why?
Esophagectomy
14
2024
131
1.460
 Why?
Carcinoma, Non-Small-Cell Lung
16
2024
1081
1.420
 Why?
Anesthesiologists
2
2021
28
1.410
 Why?
Educational Measurement
5
2023
289
1.380
 Why?
Postoperative Complications
27
2025
2654
1.290
 Why?
Education, Medical, Graduate
7
2023
486
1.280
 Why?
Anesthesia
5
2023
189
1.100
 Why?
Surgeons
7
2025
297
1.050
 Why?
Bronchiectasis
3
2012
111
1.000
 Why?
Tuberculosis, Pulmonary
3
2018
141
0.940
 Why?
Adenocarcinoma
8
2024
940
0.930
 Why?
Lung Transplantation
7
2019
313
0.920
 Why?
Robotic Surgical Procedures
6
2024
130
0.910
 Why?
Empyema, Pleural
2
2015
12
0.900
 Why?
Societies, Medical
10
2023
820
0.830
 Why?
Humans
142
2025
137585
0.810
 Why?
Perioperative Care
4
2018
178
0.790
 Why?
Neoplasm Staging
15
2024
1389
0.790
 Why?
Curriculum
7
2023
992
0.780
 Why?
Central Venous Catheters
1
2022
51
0.720
 Why?
Catheterization, Central Venous
1
2022
112
0.660
 Why?
Ultrasonography, Interventional
2
2018
141
0.650
 Why?
Minimally Invasive Surgical Procedures
6
2024
179
0.640
 Why?
Teaching
3
2021
224
0.620
 Why?
Ischemic Preconditioning
3
2024
41
0.610
 Why?
Pleura
2
2024
23
0.540
 Why?
Thoracic Wall
1
2017
18
0.540
 Why?
Practice Guidelines as Topic
6
2017
1587
0.530
 Why?
Soft Tissue Infections
1
2017
37
0.520
 Why?
Abscess
1
2017
75
0.510
 Why?
Thoracoscopy
5
2020
56
0.510
 Why?
Bronchial Fistula
2
2015
4
0.500
 Why?
Respiratory Tract Fistula
2
2015
7
0.500
 Why?
Pleural Diseases
2
2015
23
0.500
 Why?
Tomography, X-Ray Computed
10
2018
2691
0.500
 Why?
Anastomosis, Surgical
3
2024
153
0.490
 Why?
Thoracotomy
6
2019
75
0.490
 Why?
Laparoscopy
4
2024
466
0.480
 Why?
Databases, Factual
13
2025
1357
0.470
 Why?
Pneumonia, Bacterial
2
2013
116
0.470
 Why?
Female
69
2025
73304
0.470
 Why?
Male
65
2025
67762
0.470
 Why?
Osteomyelitis
1
2017
132
0.470
 Why?
Computer Simulation
5
2021
978
0.450
 Why?
Middle Aged
51
2025
33479
0.430
 Why?
Computer-Assisted Instruction
1
2014
66
0.430
 Why?
Aged
41
2025
23961
0.420
 Why?
Chest Tubes
1
2013
29
0.420
 Why?
Physicians, Women
2
2025
83
0.420
 Why?
Equipment Contamination
1
2013
67
0.410
 Why?
Length of Stay
8
2024
1215
0.410
 Why?
Treatment Outcome
20
2025
10811
0.410
 Why?
Internet
2
2014
655
0.400
 Why?
Tracheobronchomalacia
1
2012
14
0.400
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1692
0.380
 Why?
Retrospective Studies
27
2025
15657
0.380
 Why?
Anti-Bacterial Agents
6
2024
1809
0.370
 Why?
United States
24
2025
14841
0.370
 Why?
Tuberculosis, Multidrug-Resistant
1
2012
58
0.370
 Why?
Sputum
1
2013
311
0.360
 Why?
Coronary Artery Bypass
2
2015
234
0.340
 Why?
Pneumoperitoneum
1
2010
12
0.340
 Why?
Conversion to Open Surgery
2
2020
16
0.340
 Why?
Trachea
3
2022
237
0.340
 Why?
Prospective Studies
14
2024
7604
0.330
 Why?
Early Detection of Cancer
1
2015
447
0.330
 Why?
Combined Modality Therapy
6
2022
1236
0.320
 Why?
Consensus
4
2021
683
0.320
 Why?
Mass Screening
2
2015
1287
0.310
 Why?
Simulation Training
2
2021
106
0.310
 Why?
Specialties, Surgical
2
2023
75
0.290
 Why?
Heart Diseases
2
2022
346
0.290
 Why?
Small Cell Lung Carcinoma
2
2024
96
0.290
 Why?
Cost of Illness
1
2010
308
0.280
 Why?
Workflow
2
2021
165
0.270
 Why?
Mycobacterium avium-intracellulare Infection
1
2008
62
0.270
 Why?
Induction Chemotherapy
2
2024
76
0.260
 Why?
Pleural Neoplasms
2
2024
25
0.260
 Why?
Diaphragm
2
2023
42
0.260
 Why?
Airway Obstruction
2
2022
162
0.250
 Why?
Time-to-Treatment
2
2025
205
0.250
 Why?
Patient Satisfaction
1
2010
660
0.250
 Why?
Benchmarking
3
2023
186
0.250
 Why?
Postoperative Care
3
2012
261
0.250
 Why?
Esophageal Diseases
1
2006
28
0.240
 Why?
Anesthetics
2
2022
81
0.240
 Why?
Fever
1
2007
306
0.240
 Why?
Chemoradiotherapy
2
2024
225
0.240
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.240
 Why?
Thoracic Neoplasms
1
2005
37
0.230
 Why?
Genes, Plant
1
2024
50
0.220
 Why?
Prognosis
9
2024
4030
0.220
 Why?
Magnoliopsida
1
2024
33
0.220
 Why?
Patient Readmission
3
2019
697
0.210
 Why?
Preoperative Care
3
2012
362
0.210
 Why?
Esophagogastric Junction
3
2024
51
0.210
 Why?
Adult
28
2025
37929
0.210
 Why?
Esophageal Stenosis
1
2024
54
0.210
 Why?
Carcinoma, Bronchogenic
1
2003
20
0.210
 Why?
Respiratory Paralysis
1
2023
3
0.210
 Why?
Hypothermia
1
2023
36
0.210
 Why?
Aged, 80 and over
13
2024
7635
0.200
 Why?
Mentors
1
2025
202
0.200
 Why?
Plasmacytoma
1
2022
16
0.200
 Why?
Tracheal Neoplasms
1
2022
9
0.200
 Why?
Interleukin-6
1
2007
778
0.200
 Why?
Guideline Adherence
2
2024
556
0.200
 Why?
Bronchi
2
2007
260
0.200
 Why?
Biomedical Research
2
2021
692
0.200
 Why?
Propensity Score
3
2019
294
0.190
 Why?
Neoplasm Recurrence, Local
4
2024
1079
0.190
 Why?
Neoplasms, Second Primary
1
2024
118
0.190
 Why?
Ascites
1
2002
46
0.190
 Why?
Cardiovascular Diseases
4
2019
2111
0.190
 Why?
Patient Selection
5
2015
696
0.190
 Why?
Pleural Effusion
1
2002
54
0.190
 Why?
Neoadjuvant Therapy
5
2024
404
0.190
 Why?
Endometriosis
1
2002
51
0.190
 Why?
Pandemics
4
2025
1639
0.180
 Why?
Pain, Postoperative
2
2023
265
0.180
 Why?
Periodicals as Topic
1
2024
211
0.180
 Why?
Leukemia
1
2024
240
0.180
 Why?
Credentialing
1
2021
18
0.180
 Why?
Infectious Disease Transmission, Patient-to-Professional
1
2021
21
0.180
 Why?
Leadership
1
2025
388
0.170
 Why?
Interdisciplinary Research
1
2021
27
0.170
 Why?
Sarcoma
1
2003
188
0.170
 Why?
Bronchoscopy
4
2012
223
0.170
 Why?
Technology
1
2021
96
0.170
 Why?
Disease-Free Survival
4
2024
686
0.170
 Why?
Education, Distance
1
2021
50
0.170
 Why?
Cardiovascular Abnormalities
1
2020
13
0.170
 Why?
Subclavian Artery
1
2020
28
0.170
 Why?
Developing Countries
1
2022
307
0.160
 Why?
Carotid Artery, Common
1
2020
36
0.160
 Why?
Phylogeny
1
2024
904
0.160
 Why?
Evolution, Molecular
1
2024
493
0.160
 Why?
Robotics
1
2021
94
0.160
 Why?
Anastomotic Leak
3
2024
41
0.160
 Why?
Stomach
3
2024
110
0.150
 Why?
Survival Rate
5
2024
1972
0.150
 Why?
General Surgery
1
2021
173
0.150
 Why?
Educational Status
1
2021
470
0.150
 Why?
Quality of Life
3
2024
2892
0.150
 Why?
Metastasectomy
1
2018
20
0.150
 Why?
Feasibility Studies
3
2018
956
0.150
 Why?
Genomics
1
2024
795
0.150
 Why?
Manikins
1
2018
29
0.140
 Why?
Pulmonary Emphysema
2
2015
288
0.140
 Why?
Carcinoma, Squamous Cell
3
2012
683
0.140
 Why?
Anesthesia, Cardiac Procedures
1
2017
6
0.140
 Why?
Cohort Studies
5
2019
5742
0.140
 Why?
Forms and Records Control
1
2017
23
0.130
 Why?
Negative-Pressure Wound Therapy
1
2017
27
0.130
 Why?
Pylorus
1
2017
18
0.130
 Why?
Gastric Outlet Obstruction
1
2017
12
0.130
 Why?
Learning
1
2021
409
0.130
 Why?
Pain Management
1
2020
352
0.130
 Why?
NADPH Oxidases
1
2017
113
0.130
 Why?
Clinical Protocols
3
2024
271
0.130
 Why?
Frailty
1
2019
170
0.130
 Why?
Neuromuscular Agents
1
2017
35
0.130
 Why?
CD4-Positive T-Lymphocytes
2
2017
1091
0.130
 Why?
Antigen Presentation
1
2017
218
0.130
 Why?
Botulinum Toxins, Type A
1
2017
45
0.120
 Why?
Faculty, Medical
1
2018
283
0.120
 Why?
Program Development
1
2017
364
0.120
 Why?
Lymphocytes, Tumor-Infiltrating
1
2017
210
0.120
 Why?
Extracorporeal Membrane Oxygenation
1
2019
301
0.120
 Why?
Cause of Death
1
2017
434
0.120
 Why?
Documentation
1
2017
194
0.120
 Why?
Patient-Centered Care
1
2020
530
0.110
 Why?
Asphyxia
1
2014
20
0.110
 Why?
Risk Factors
7
2024
10388
0.110
 Why?
Radiotherapy Dosage
1
2015
268
0.110
 Why?
Chronic Disease
3
2017
1793
0.110
 Why?
Kidney Neoplasms
2
2009
403
0.110
 Why?
Risk
2
2015
912
0.110
 Why?
Chemotherapy, Adjuvant
2
2005
389
0.110
 Why?
Intubation, Intratracheal
1
2016
257
0.110
 Why?
Pulmonary Disease, Chronic Obstructive
2
2015
1040
0.110
 Why?
Dyspnea
2
2023
254
0.110
 Why?
Suture Techniques
2
2006
122
0.110
 Why?
Diabetes Mellitus
1
2022
1040
0.110
 Why?
Myocardial Infarction
1
2021
1046
0.100
 Why?
Health Expenditures
1
2015
189
0.100
 Why?
Perfusion
1
2014
213
0.100
 Why?
Accreditation
2
2023
83
0.100
 Why?
Patient Discharge
1
2019
897
0.100
 Why?
Group II Phospholipases A2
1
2012
9
0.100
 Why?
Carcinoma, Large Cell
1
2012
16
0.100
 Why?
Extensively Drug-Resistant Tuberculosis
1
2012
6
0.100
 Why?
Consumer Health Information
1
2013
47
0.100
 Why?
Mutation
3
2022
3958
0.100
 Why?
Cardiology
1
2015
274
0.100
 Why?
Radiography
1
2014
822
0.100
 Why?
Ultrasonography
1
2016
759
0.100
 Why?
Time Factors
5
2024
6828
0.090
 Why?
Cost-Benefit Analysis
1
2015
591
0.090
 Why?
Volatile Organic Compounds
1
2012
61
0.090
 Why?
B-Lymphocytes
1
2017
847
0.090
 Why?
Tracheal Stenosis
1
2012
31
0.090
 Why?
ErbB Receptors
2
2022
614
0.090
 Why?
ras Proteins
1
2012
153
0.090
 Why?
Cardiac Surgical Procedures
2
2017
530
0.090
 Why?
Physician's Role
1
2013
211
0.090
 Why?
Logistic Models
4
2019
2074
0.090
 Why?
Risk Assessment
4
2023
3457
0.090
 Why?
Smoking
2
2017
1627
0.090
 Why?
Atrial Flutter
1
2011
35
0.090
 Why?
Morbidity
3
2023
324
0.090
 Why?
Antitubercular Agents
1
2012
206
0.080
 Why?
Mycobacterium Infections
1
2011
63
0.080
 Why?
Tissue and Organ Procurement
1
2014
321
0.080
 Why?
Quality Improvement
4
2020
1178
0.080
 Why?
Hemoptysis
1
2010
36
0.080
 Why?
Syndrome
1
2011
358
0.080
 Why?
Oxidative Stress
1
2017
1317
0.080
 Why?
Patient Reported Outcome Measures
2
2024
402
0.080
 Why?
Hospital Costs
1
2010
117
0.080
 Why?
Mycobacterium
1
2011
108
0.080
 Why?
Neoplasm Invasiveness
3
2024
510
0.080
 Why?
Carcinoma, Papillary
1
2009
81
0.080
 Why?
DNA-Binding Proteins
1
2017
1502
0.080
 Why?
Follow-Up Studies
3
2024
5131
0.080
 Why?
Teratoma
1
2010
114
0.080
 Why?
Kaplan-Meier Estimate
2
2023
889
0.080
 Why?
Enzyme Inhibitors
1
2012
840
0.080
 Why?
Proto-Oncogene Proteins
1
2012
648
0.080
 Why?
Reoperation
2
2008
573
0.070
 Why?
Lymph Nodes
2
2023
491
0.070
 Why?
Transcription Factors
1
2017
1719
0.070
 Why?
Registries
1
2016
2035
0.070
 Why?
Intraoperative Care
1
2008
52
0.070
 Why?
Carcinoid Tumor
1
2008
26
0.070
 Why?
Mountaineering
1
2008
40
0.070
 Why?
Stents
1
2012
527
0.070
 Why?
Vena Cava, Inferior
1
2008
71
0.070
 Why?
Positron-Emission Tomography
2
2009
294
0.070
 Why?
Thrombectomy
1
2008
69
0.070
 Why?
Multivariate Analysis
3
2019
1509
0.070
 Why?
Spectral Karyotyping
1
2007
5
0.070
 Why?
Neoplasm, Residual
1
2008
133
0.070
 Why?
Li-Fraumeni Syndrome
1
2007
14
0.070
 Why?
Heart Failure
1
2021
2236
0.070
 Why?
Respiratory Sounds
1
2008
125
0.070
 Why?
Nephrectomy
1
2008
169
0.070
 Why?
Surgical Flaps
1
2008
130
0.070
 Why?
Barrett Esophagus
1
2009
149
0.070
 Why?
Atrial Fibrillation
1
2011
388
0.070
 Why?
Renal Dialysis
1
2011
435
0.070
 Why?
Pyrimidines
1
2010
470
0.060
 Why?
Reproducibility of Results
3
2023
3284
0.060
 Why?
Chromosome Aberrations
1
2007
156
0.060
 Why?
Urinary Bladder Neoplasms
1
2009
252
0.060
 Why?
Sulfonamides
1
2010
513
0.060
 Why?
Carbonic Anhydrases
1
2006
14
0.060
 Why?
Vascular Surgical Procedures
1
2009
303
0.060
 Why?
Mediastinoscopy
1
2005
5
0.060
 Why?
Fatigue
2
2023
329
0.060
 Why?
Sialoglycoproteins
1
2006
159
0.060
 Why?
Hyaluronan Receptors
1
2006
102
0.060
 Why?
Precancerous Conditions
1
2007
169
0.060
 Why?
Decision Making
1
2013
900
0.060
 Why?
Carcinoma, Renal Cell
1
2008
217
0.060
 Why?
Delivery of Health Care
1
2013
951
0.060
 Why?
Insulin Infusion Systems
1
2009
394
0.060
 Why?
Blood Loss, Surgical
1
2005
101
0.060
 Why?
Hospital Mortality
2
2019
911
0.060
 Why?
Radiotherapy, Adjuvant
1
2005
220
0.060
 Why?
Heart-Lung Transplantation
1
2004
14
0.060
 Why?
Chylothorax
1
2004
16
0.050
 Why?
Odds Ratio
2
2019
1070
0.050
 Why?
Emergencies
1
2025
164
0.050
 Why?
Diagnosis, Differential
2
2010
1483
0.050
 Why?
Antineoplastic Agents
2
2012
2129
0.050
 Why?
Cytogenetic Analysis
1
2003
33
0.050
 Why?
Fossils
1
2024
75
0.050
 Why?
Apoptosis
1
2012
2553
0.050
 Why?
Antigens, Neoplasm
1
2006
319
0.050
 Why?
Contraindications
1
2003
90
0.050
 Why?
Biomarkers, Tumor
2
2007
1276
0.050
 Why?
Constriction, Pathologic
1
2024
245
0.050
 Why?
Evidence-Based Medicine
2
2017
740
0.050
 Why?
Mesoderm
1
2003
144
0.050
 Why?
Airway Management
1
2022
52
0.050
 Why?
Advisory Committees
1
2023
219
0.050
 Why?
Lung
4
2024
4060
0.050
 Why?
Cell Survival
2
2017
1120
0.050
 Why?
Sex Factors
1
2007
2071
0.040
 Why?
Oxygen
1
2006
931
0.040
 Why?
Operating Rooms
1
2022
123
0.040
 Why?
Learning Curve
1
2021
72
0.040
 Why?
Data Warehousing
1
2020
6
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2022
234
0.040
 Why?
Socioeconomic Factors
1
2024
1289
0.040
 Why?
Case-Control Studies
2
2024
3556
0.040
 Why?
Intermediate Care Facilities
1
2019
3
0.040
 Why?
Recurrence
1
2023
1060
0.040
 Why?
Survival Analysis
2
2017
1325
0.040
 Why?
Gene Expression Regulation, Neoplastic
3
2012
1396
0.040
 Why?
Margins of Excision
1
2019
50
0.040
 Why?
Psychometrics
1
2023
720
0.040
 Why?
Walk Test
1
2019
76
0.040
 Why?
Imaging, Three-Dimensional
1
2003
580
0.040
 Why?
Nuclear Proteins
1
2024
712
0.040
 Why?
Cytokines
1
2007
2085
0.040
 Why?
Cross-Sectional Studies
2
2022
5472
0.040
 Why?
Serum Albumin
1
2019
150
0.040
 Why?
Insulin
1
2009
2409
0.040
 Why?
Radiography, Thoracic
2
2010
167
0.040
 Why?
Sarcopenia
1
2019
83
0.040
 Why?
Qualitative Research
1
2025
1386
0.040
 Why?
Skilled Nursing Facilities
1
2019
141
0.040
 Why?
Lymphocyte Count
1
2017
148
0.030
 Why?
Algorithms
1
2005
1704
0.030
 Why?
Patient Care Team
1
2022
631
0.030
 Why?
NADPH Oxidase 4
1
2017
8
0.030
 Why?
Antigen-Presenting Cells
1
2017
156
0.030
 Why?
Glutathione Disulfide
1
2017
33
0.030
 Why?
Continuity of Patient Care
1
2019
284
0.030
 Why?
Regression Analysis
1
2019
1024
0.030
 Why?
Gastric Emptying
1
2017
38
0.030
 Why?
Geography
1
2017
200
0.030
 Why?
Incidence
1
2023
2804
0.030
 Why?
Superoxides
1
2017
202
0.030
 Why?
Immunophenotyping
1
2017
318
0.030
 Why?
Gastroepiploic Artery
1
2015
4
0.030
 Why?
Home Care Services
1
2019
257
0.030
 Why?
Mammary Arteries
1
2015
7
0.030
 Why?
Cytoplasm
1
2017
274
0.030
 Why?
Inflammation
1
2007
2837
0.030
 Why?
Writing
1
2017
95
0.030
 Why?
Academic Medical Centers
1
2018
512
0.030
 Why?
Radial Artery
1
2015
68
0.030
 Why?
Green Fluorescent Proteins
1
2017
390
0.030
 Why?
Task Performance and Analysis
1
2016
183
0.030
 Why?
Fluorescent Dyes
1
2017
321
0.030
 Why?
Adaptor Proteins, Signal Transducing
1
2017
430
0.030
 Why?
Focus Groups
1
2016
522
0.030
 Why?
Lymphocyte Activation
1
2017
1142
0.030
 Why?
Tumor Microenvironment
1
2017
674
0.030
 Why?
Oxidation-Reduction
1
2017
1060
0.030
 Why?
Antioxidants
1
2017
584
0.030
 Why?
Solid Phase Microextraction
1
2012
9
0.020
 Why?
Young Adult
3
2014
13209
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2012
132
0.020
 Why?
Breath Tests
1
2012
87
0.020
 Why?
Gastroscopy
1
2012
19
0.020
 Why?
Silicones
1
2012
25
0.020
 Why?
Foreign-Body Migration
1
2012
34
0.020
 Why?
Analgesics, Opioid
1
2020
1000
0.020
 Why?
Biomechanical Phenomena
1
2015
810
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
171
0.020
 Why?
Fibroblasts
1
2017
996
0.020
 Why?
Gene Expression Regulation, Enzymologic
1
2012
283
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
1
2012
267
0.020
 Why?
Gene Expression Profiling
2
2010
1774
0.020
 Why?
Lymphatic Metastasis
1
2012
352
0.020
 Why?
Forced Expiratory Volume
1
2012
531
0.020
 Why?
Device Removal
1
2012
136
0.020
 Why?
Debridement
1
2011
81
0.020
 Why?
False Positive Reactions
1
2011
115
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
976
0.020
 Why?
Artifacts
1
2011
129
0.020
 Why?
Air
1
2010
37
0.020
 Why?
Global Health
1
2013
386
0.020
 Why?
Adolescent
3
2014
21513
0.020
 Why?
Indazoles
1
2010
69
0.020
 Why?
Blotting, Western
1
2012
1226
0.020
 Why?
Chest Pain
1
2010
91
0.020
 Why?
Surveys and Questionnaires
1
2022
5778
0.020
 Why?
Mice, Knockout
1
2017
3015
0.020
 Why?
Molecular Targeted Therapy
1
2012
411
0.020
 Why?
Diarrhea
1
2010
184
0.020
 Why?
Photochemotherapy
1
2009
44
0.020
 Why?
Attitude of Health Personnel
1
2017
1171
0.020
 Why?
NF-kappa B
1
2012
691
0.020
 Why?
Drug Administration Schedule
1
2010
786
0.020
 Why?
Dose-Response Relationship, Drug
1
2012
2057
0.020
 Why?
Phosphorylation
1
2012
1759
0.020
 Why?
Administration, Oral
1
2010
816
0.020
 Why?
Cisplatin
1
2009
320
0.020
 Why?
Esophagoscopy
1
2009
209
0.020
 Why?
Electrocardiography
1
2011
629
0.020
 Why?
Decompression, Surgical
1
2008
106
0.020
 Why?
Gene Expression Regulation
1
2017
2607
0.020
 Why?
Pilot Projects
1
2012
1710
0.020
 Why?
Suicide
1
2014
656
0.020
 Why?
Carbonic Anhydrase IX
1
2006
4
0.020
 Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
19
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2007
317
0.020
 Why?
Osteopontin
1
2006
33
0.020
 Why?
Tegafur
1
2005
3
0.020
 Why?
Biomarkers
1
2017
4149
0.020
 Why?
Platinum Compounds
1
2005
10
0.020
 Why?
Uracil
1
2005
31
0.020
 Why?
Lymphatic Diseases
1
2005
22
0.020
 Why?
Tracheal Diseases
1
2005
15
0.020
 Why?
Population Surveillance
1
2009
482
0.020
 Why?
Catheter Ablation
1
2009
350
0.010
 Why?
Biopsy
1
2009
1129
0.010
 Why?
Mediastinal Neoplasms
1
2005
45
0.010
 Why?
Drainage
1
2006
173
0.010
 Why?
Kidney Failure, Chronic
1
2011
570
0.010
 Why?
Age Factors
1
2012
3295
0.010
 Why?
Clone Cells
1
2005
265
0.010
 Why?
Lymphoma, Non-Hodgkin
1
2005
87
0.010
 Why?
Meta-Analysis as Topic
1
2005
186
0.010
 Why?
Cell Line, Tumor
1
2012
3412
0.010
 Why?
Aminocaproates
1
2004
2
0.010
 Why?
Respiratory Mucosa
1
2007
321
0.010
 Why?
RNA, Messenger
1
2012
2833
0.010
 Why?
Decision Trees
1
2004
93
0.010
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
767
0.010
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2005
336
0.010
 Why?
Mediastinum
1
2002
23
0.010
 Why?
Sensitivity and Specificity
1
2007
1946
0.010
 Why?
Lymph Node Excision
1
2002
171
0.010
 Why?
Hypertension
1
2010
1295
0.010
 Why?
Clinical Trials as Topic
1
2005
1050
0.010
 Why?
Cells, Cultured
1
2007
4193
0.010
 Why?
Blood Glucose
1
2009
2186
0.010
 Why?
Animals
1
2017
36940
0.010
 Why?
Mitchell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (437) concept(s)
_
Co-Authors Expand Description
See all (71) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)